Iranian Heart Journal

Iranian Heart Journal

Serum Magnesium Level and Severity of Coronary Artery Disease

Document Type : Original Article

Authors
1 Department of Cardiology, School of Medicine Birjand University of Medical Sciences, Birjand, IR Iran.
2 Cardiovascular Research Center, Institute of Basic and Clinical Physiology Sciences, Kerman University of Medical Sciences, Kerman, IR Iran.
Abstract
Objectives: In the present study, we aimed to investigate the relationship between serum magnesium level and the severity of coronary artery disease (CAD) and to determine whether lower magnesium levels are associated with more advanced coronary artery stenosis based on angiography and SYNTAX scoring.

Methods: This cross-sectional study involved 203 patients who underwent elective coronary angiography at Shafa Hospital in Kerman, Iran, between 2023 and 2024. An initial stratification divided the patients into 2 groups based on angiographic evidence: normal angiography and coronary artery occlusion. The patients with blockages were further divided into nonsevere and severe CAD groups using the SYNTAX score. Serum magnesium level was measured before angiography. Researchers also recorded demographic and clinical data. Serum magnesium levels were assessed for normality using the Kolmogorov-Smirnov test, and the Kruskal-Wallis test was used for group comparisons.

Results: The mean serum magnesium level was 2.52 (SD, 0.21) mg/dL in the normal group, 2.34 (SD, 0.27) mg/dL in the nonsevere CAD group, and 1.89 (SD, 0.25) mg/dL in the severe CAD group. There was a strong inverse relationship between magnesium levels and CAD severity (P < .001).

Conclusions: Lower serum magnesium levels were significantly associated with greater severity of CAD. These findings highlight a potential association between serum magnesium status and the extent of CAD. Still, further prospective studies are needed to clarify the clinical significance of this relationship. (Iranian Heart Journal 2026; 27(4): 73-79)
Keywords

1.         Dalen JE, Alpert JS, Goldberg RJ, Weinstein RS. The epidemic of the 20th century: coronary heart disease. Am J Med. 2014; 127(9):807–12. doi:10.1016/j.amjmed.2014.04.015.
2.         Volpe SL. Magnesium, the metabolic syndrome, insulin resistance, and type 2 diabetes mellitus. Crit Rev Food Sci Nutr. 2008;48(3):293–300. doi:10.1080/10408390701326235.
3.         Nakahara T, Dweck MR, Narula N, Pisapia D, Narula J, Strauss HW. Coronary artery calcification: from mechanism to molecular imaging. JACC Cardiovasc Imaging. 2017 May;10(5):582-593. doi:10.1016/j.jcmg.2017.03.005.
4.         Jamal A, Phillips E, Gentzke AS, Homa DM, Babb SD, King BA, et al. Current cigarette smoking among adults - United States, 2016. MMWR Morb Mortal Wkly Rep. 2018 Jan 19; 67(2):53-59. doi:10.15585/mmwr.mm6702a1.
5.         Kolte D, Vijayaraghavan K, Khera S, Sica DA, Frishman WH. Role of magnesium in cardiovascular diseases. Cardiol Rev. 2014 Jul-Aug;22(4):182-92. doi:10.1097/CRD.0000000000000003.
6.         Cunha AR, D'El-Rei J, Medeiros F, Umbelino B, Oigman W, Touyz RM, et al. Oral magnesium supplementation improves endothelial function and attenuates subclinical atherosclerosis in thiazide-treated hypertensive women. J Hypertens. 2017 Jan; 35(1):89-97. doi:10.1097/HJH.0000000000001129.
7.         Shechter M, Sharir M, Labrador MJ, Forrester J, Silver B, Bairey Merz CN. Oral magnesium therapy improves endothelial function in patients with coronary artery disease. Circulation. 2000 Nov 7; 102(19):2353-8. doi:10.1161/01.cir.102.19.2353.
8.         Zhang X, Li Y, Del Gobbo LC, Rosanoff A, Wang J, Zhang W, et al. Effects of Magnesium Supplementation on Blood Pressure: A Meta-Analysis of Randomized Double-Blind Placebo-Controlled Trials. Hypertension. 2016 Aug; 68(2):324-33. doi: 10.1161/HYPERTENSIONAHA.116.07664.
9.         Verma H, Garg R. Effect of magnesium supplementation on type 2 diabetes associated cardiovascular risk factors: a systematic review and meta-analysis. J Hum Nutr Diet. 2017 Oct; 30(5):621-633. doi:10.1111/jhn.12454.
10.      Song Y, He K, Levitan EB, Manson JE, Liu S. Effects of oral magnesium supplementation on glycaemic control in Type 2 diabetes: a meta-analysis of randomized double-blind controlled trials. Diabet Med. 2006 Oct; 23(10):1050-6. doi:10.1111/j.1464-5491.2006.01852.x.
11.      Simental-Mendía LE, Sahebkar A, Rodríguez-Morán M, Guerrero-Romero F. A systematic review and meta-analysis of randomized controlled trials on the effects of magnesium supplementation on insulin sensitivity and glucose control. Pharmacol Res. 2016 Sep; 111:272-282. doi:10.1016/j.phrs.2016.06.019.
12.      Lee HY, Ghimire S, Kim EY. Magnesium supplementation reduces postoperative arrhythmias after cardiopulmonary bypass in pediatrics: a metaanalysis of randomized controlled trials. Pediatr Cardiol. 2013 Aug; 34(6):1396-403. doi: 10.1007/s00246-013-0658-8.
13.      Shiga T, Wajima Z, Inoue T, Ogawa R. Magnesium prophylaxis for arrhythmias after cardiac surgery: a meta-analysis of randomized controlled trials. Am J Med. 2004 Sep 1; 117(5):325-33. doi:10.1016/j.amjmed.2004.03.030.
14.      Stühlinger H-G. Magnesium in cardiovascular disease. J. Clin. Basic Cardiol. 2002; 5(1):55–59.
15.      de Baaij JH, Hoenderop JG, Bindels RJ. Magnesium in man: implications for health and disease. Physiol Rev. 2015 Jan; 95(1):1-46. doi: 10.1152/physrev.00012.2014.
16.      Allen MJ, Sharma S. Magnesium. 2023 Feb 20. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–. PMID: 30085578.
17.      Mahalle N, Kulkarni MV, Naik SS. Is hypomagnesaemia a coronary risk factor among Indians with coronary artery disease? J Cardiovasc Dis Res. 2012 Oct; 3(4):280-6. doi: 10.4103/0975-3583.102698.
18.      Chiuve SE, Sun Q, Curhan GC, Taylor EN, Spiegelman D, Willett WC, et al. Dietary and plasma magnesium and risk of coronary heart disease among women. J Am Heart Assoc. 2013 Mar 18; 2(2):e000114. doi:10.1161/JAHA.113.000114.